Physician profile
Daniel Jay Levy
NPI 1124010632
$2,255.48
in general payments reported to CMS, 2019-2025
25 companies · $124 in 2025
The $124 reported for 2025 was more than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $469 · 2020: $84.38 · 2021: $138 · 2022: $268 · 2023: $661 · 2024: $512 · 2025: $124.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,296.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,296.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corium, LLC | $293.46 | 2022-2024 | Azstarys |
| Tris Pharma INC | $268.63 | 2019-2025 | Dyanavel Xr |
| Ironshore Pharmaceuticals INC. | $207.30 | 2019-2024 | |
| Pfizer INC. | $194.10 | 2019-2025 | |
| Supernus Pharmaceuticals, INC. | $182.81 | 2024 | Qelbree |
| Takeda Pharmaceuticals U.S.A., INC. | $161.32 | 2019-2022 | |
| Neos Therapeutics, Lp | $118.41 | 2019 | |
| Sanofi Pasteur INC. | $109.83 | 2019-2024 | |
| Merck Sharp & Dohme LLC | $108.33 | 2019-2023 | Vaxneuvance, Vaxelis, Proquad |
| Cranial Technologies, INC | $100.94 | 2019-2024 | Doc Band |
| Abbott Laboratories | $99.88 | 2023 | Amplatzer Piccolo |
| Cognoa, INC. | $57.40 | 2023 | Canvas Dx |
| Shire North American Group INC | $48.14 | 2019 | |
| Glaxosmithkline, LLC. | $45.94 | 2023-2024 | Bexsero |
| Kaleo, INC. | $42.36 | 2021-2022 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Phadia US INC. | $35.56 | 2023-2024 | Immunocap |
| Acadia Pharmaceuticals INC | $28.28 | 2024 | Daybue |
| Alk-Abello, INC | $27.66 | 2025 | Odactra, Ragwitek, Grastek |
| Collegium Pharmaceutical, INC. | $24.36 | 2025 | Jornay Pm |
| Alexion Pharmaceuticals, INC. | $19.72 | 2023 | |
| Cumberland Pharmaceuticals, INC. | $19.29 | 2024 | Kristalose |
| Astrazeneca Pharmaceuticals Lp | $18.26 | 2023 | Flumist Quadrivalent |
| Ars Pharmaceuticals Operations, INC. | $14.68 | 2025 | Neffy |
| Viiv Healthcare Company | $14.54 | 2025 | Apretude |
| Adlon Therapeutics L.P. | $14.28 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Levy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.